Effects of haloperidol on reactions to smoking cues in humans

Behavioural Pharmacology

Volumn 16, Issue 2, 2005, Pages 123-126

  Mahler, S V ^a   De Wit, H ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Craving; Cues; Dopamine; Haloperidol; Human; Smoking

Indexed keywords

DOPAMINE RECEPTOR BLOCKING AGENT; HALOPERIDOL; NICOTINE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG EFFECT; FEMALE; HEART RATE; HUMAN; MALE; REACTION TIME; SMOKING CESSATION; SMOKING HABIT; TACTILE STIMULATION; VISUAL STIMULATION; WITHDRAWAL SYNDROME;

ADULT; CONDITIONING (PSYCHOLOGY); DOPAMINE ANTAGONISTS; DOUBLE-BLIND METHOD; FEMALE; HALOPERIDOL; HEART RATE; HUMANS; MALE; PLACEBOS; RECEPTORS, DOPAMINE; REINFORCEMENT (PSYCHOLOGY); SMOKING; TOUCH; VISUAL PERCEPTION;

EID: 16444376652     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-200503000-00008     Document Type: Article

References (23)

1. Alsene KA, Li Y, Chaverneff F, de Wit H (2003). Role of abstinence and visual cues on food and smoking craving. Behav Pharmacol 14:145-151.
2. Balfour DJ, Wright AE, Benwell ME, Birrell CE (2000). The putative role of extra-synaptic mesolimbic dopamine in the neurobiology of nicotine dependence. Behav Brain Res 113:73-83.
3. Berger SP, Hall S, Mickalian JD, Reid MS, Crawford CA, Delucchi K, et al. (1996). Haloperidol antagonism of cue-elicited cocaine craving. Lancet 347:504-508.
4. Berridge KC, Robinson TE (1998). What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Rev 28:309-369.
5. Brauer LH, Cramblett MJ, Paxton DA, Rose JE (2001). Haloperidol reduces smoking of both nicotine-containing and denicotinized cigarettes. Psychopharmacology (Berl) 159:31-37.
6. Carter BL, Tiffany ST (1999). Meta-analysis of cue-reactivity in addiction research. Addiction 94:327-340.
7. Caskey NH, Jarvik ME, Wirshing WC (1999). The effects of dopaminergic D2 stimulation and blockade on smoking behaviour. Experimental and Clinical Psychopharmacology 7:72-78.
8. Caskey NH, Jarvik ME, Wishing WC, Madsen DC, Iwamoto-Schaap PN, Eisenberger NI, et al. (2002). Modulating tobacco smoking rates by dopaminergic stimulation and blockade. Nicotine Tobacco Res 4:259-266.
9. Childress AR, Mozley PD, McElgin W, Fitzgerald J, Reivich M, O'Brien CP (1999). Limbic activation during cue-induced cocaine craving. Am J Psychiatry 156:11-18.
10. Cox LS, Tiffany ST, Christen AG (2001). Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine Tobacco Res 3:7-16.
11. Dawe S, Gerada C, Russell MA, Gray JA (1995). Nicotine intake in smokers increases following a single dose of haloperidol. Psychopharmacology (Berl) 117:110-115.
12. Due DL, Huettel SA, Hall WG, Rubin DC (2002). Activation in mesolimbic and visuospatial neural circuits elicited by smoking cues: evidence from functional magnetic resonance imaging. Am J Psychiatry 159:954-960.
13. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO (1991). The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 86:1119-1127.
14. Hutchison KE, Rutter MC, Niaura R, Swift RM, Pickworth WB, Sobik L (2004). Olanzapine attenuates cue-elicited craving for tobacco. Psychopharmacology (Berl) 175:407-413.
15. Kilts CD, Schweitzer JB, Quinn CK, Gross RE, Faber TL, Muhammad F, et al. (2001). Neural activity related to drug craving in cocaine addiction. Arch Gen Psychiatry 58:334-341.
16. Magliozzi JR, Gillespe H, Lombrozo L, Hollister LE (1985), Mood alterations following oral and intravenous haloperidol and relationship to drug concentrations in normal subjects. J Clin Pharmacol 25:285-290.
17. Martin WR, Sloan JW, Sapira JD, Jasinski DR (1971). Physiologic, subjective and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther 12:245-258.
18. Nordstrom AL, Farde L, Halldin C (1992). Time course of D2-dopamine receptor occupancy examined by PET after single oral doses of haloperidol. Psychopharmacology 106:433-438.
19. Robinson TE, Berridge KC (2001). Incentive sensitizatton and addiction, Addiction 96:103-114.
20. Sayette MA. Hufford MR (1994). Effects of cue exposure and deprivation on cognitive resources in smokers. J Abnorm Psychol 103:812-818.
21. Stewart J, de Wit H, Eikelboom R (1984). The role of unconditioned and conditioned drug effects in the self-administration of opiates and stimulants. Psychol Rev 91:251-268.
22. Tiffany ST, Cox LS, Elash CA (2000). Effects of transdermal nicotine patches on abstinence-induced and cue-induced craving in cigarette smokers. J Consult Clin Psychol 68:233-240.
23. Wachtel SR, Ortengren A, de Wit H (2002). The effects of acute haloperidol or risperidone on subjective responses to methamphetamine in healthy volunteers. Drug Alcohol Depend 68:23-33.